Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cybin Inc (NY: CYBN )

0.3626 -0.0082 (-2.21%)
Streaming Delayed Price Updated: 10:26 AM EDT, Apr 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cybin Inc

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Revive Therapeutics, Field Trip Health Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.48% at $0.14 
Via Benzinga
Cybi (NEO: CYBN) (NYSE American: CYBN) To Participate In Benzinga Psychedelics Conference
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 4.78% at $19.73 LOSERS: 
Via Benzinga
A Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our Speakers
From his beginnings at DuPont Merck to his current position as Cybin’s (NYSE: CYBN) CEO, Doug Drysdale has certainly had an ... 
Via Benzinga
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
It’s earnings week in the psychedelics space, opening a new window into the financial situations of many companies in the sector. 
Via Benzinga
Cybin Subsidiary Achieves Milestone
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Cybin Planning Pilot Study Of CYB004
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Psychedelic Stock Gainers And Losers From April 5, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 1.60% at $1.27 LOSERS: 
Via Benzinga
Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.06% at $14.18 
Via Benzinga
Cybin's (NYSE American: CYBN) (NEO: CYBN) Adelia Therapeutics Achieves New Milestone
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
3 Psychedelic Stocks to Buy for Oregon’s Magic Mushroom Bill
Psychedelic medical treatments and therapies are gaining in popularity, and these psychedelic stocks could benefit as the market emerges. 
Via InvestorPlace
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Cybin (AMEX:CYBN) shares closed up 5.26% at $0.86 
Via Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Announces Commencement Of Kernel Flow(R) Study
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.   
Via Benzinga
March Update: Psychedelic Compounds-Based Drug Stocks Index Went Down -19%
An update on the revisions that have been made to the Pure-Play Psychedelic Compounds-Based Drug Stocks Index with the increase in the minimum market capitalization required to be included in the... 
Via Talk Markets
Field Trip Health, Revive Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 3.38% at $0.27 
Via Benzinga
Cybin Begins Study Using Kernel Flow Headsets To Measure Ketamine's Effects On The Brain
The first study visit to measurethe psychedelic effects of ketamine in the cerebral cortex blood flowis underway, ... 
Via Benzinga
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 4.22% at $0.46 
Via Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Announces Milestone In CYB003 Program
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 29, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 9.05% at $5.42 
Via Benzinga
Cybin Completes In Vivo Preclinical Studies For Major Depressive Disorder
Cybin Inc.(NYSE: CYBN) announced that its in vivo preclinical studies evaluating the proprietary drug CYB003 are completed. ... 
Via Benzinga
Mindset Pharma, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 8.24% at $0.18 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 25, 2022
GAINERS: Allied (OTC: 
Via Benzinga
Allied, Field Trip Health Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC: 
Via Benzinga
Five Companies Developing Second Generation Psychedelics For Mental Health
Along with the psychedelic renaissance came a new type of drug: second generation psychedelics. Developed from classic psychedelics ... 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 23, 2022
GAINERS: Compass Pathways (NASDAQ: 
Via Benzinga
Mindset Pharma, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Mind Medicine (NASDAQ: 
Via Benzinga
Field Trip Health, Mindset Pharma Among Top Psychedelic Movers Of Today
GAINERS: Field Trip Health (NASDAQ: 
Via Benzinga
Psychedelic Compounds-Based Drug Stocks Index Bounces Back
Updating the stock performances of the 13 constituents in our Pure-Play Marijuana and Psychedelic Compounds-Based Drug Stocks Index: up last week but still down 32% YTD. 
Via Talk Markets
Field Trip Health, Allied Among Top Psychedelic Movers Of Today
GAINERS: Field Trip Health (NASDAQ: 
Via Benzinga
Psychedelic Stock Gainers And Losers From March 16, 2022
GAINERS: Mindset Pharma (OTC: 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.